Image Analysis

PathAI PathExplore™ panel will empower oncology drug developers with improved tumor microenvironment spatial characterization from H&E, propelling a new phase of precision medicine. BOSTON, April 4, 2023 /PRNewswire/ -- PathAI, a...

TOKYO, (April 03, 2023)— Evident Corporation (“Evident”) announced today that it has been acquired by private equity firm Bain Capital Private Equity (“Bain Capital”) from Olympus Corporation (“Olympus”) pursuant to the definitive...

Andy Beck of PathAI: AI will continue to get better over time. Systems are continually improving and will be considerably more advanced looking ahead just five years from now. This expectation of progress gives us in the AI industry optimism...

Samsung Medical Center has demonstrated the most comprehensive use of an integrated digital pathology to date. Given a rapidly aging population and an overwhelmed health system, hospitals like Samsung Medical Center had to deal with rising...

Deep Bio: USCAP 2023 is sixth consecutive year of presenting research abstracts  SEOUL, SOUTH KOREA (PRWEB) MARCH 14, 2023 - Deep Bio, a pioneer in medical AI for digital pathology and cancer diagnostics support software shared three...

Concord, MA and Singapore, March 12, 2023 – Corista, a leading provider of clinical, research and educational digital pathology image management solutions, and Qritive, a leading developer of artificial intelligence (AI)-powered cancer...